Identification of Epclusa:
No description |
Search images on Google Product Monograph
Active Ingredients:
- velpatasvir, 100 MG
- sofosbuvir, 400 MG
DIN: 02456370
Dosage Form(s): TABLET
Route(s) of Administration: ORAL
Schedule: Prescription
Company: GILEAD SCIENCES CANADA INC
ATC:
- J05 - ANTIVIRALS FOR SYSTEMIC USE (ATC, WHO, Wiki)
- J05A - DIRECT ACTING ANTIVIRALS (ATC, WHO)
- J05AP - (ATC, WHO)
- J05AP55 - SOFOSBUVIR AND VELPATASVIR (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 28